Fucoidan stimulation induces a functional maturation of human monocyte-derived dendritic cells

International Immunopharmacology

Volumn 8, Issue 13-14, 2008, Pages 1754-1760

  Yang, Meixiang ^a,b   Ma, Chunhong ^b   Sun, Jintang ^a   Shao, Qianqian ^a   Gao, Wenjuan ^a   Zhang, Yan ^a   Li, Zewu ^a   Xie, Qi ^a   Dong, Zhaogang ^a   Qu, Xun ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

Fucoidan; Human monocyte derived dendritic cells; Immunomodulatory capacity

Indexed keywords

DENDRITIC CELL VACCINE; FUCOIDIN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA DR ANTIGEN; IMMUNOMODULATING AGENT; INTERLEUKIN 12; INTERLEUKIN 12P70; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CANCER IMMUNOTHERAPY; CELL ACTIVATION; CELL CULTURE; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CYTOKINE RELEASE; DENDRITIC CELL; ENDOCYTOSIS; HELPER CELL; HUMAN; HUMAN CELL; IMMUNOMODULATION; MIXED LYMPHOCYTE REACTION; MONOCYTE; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; TH1 CELL; UPREGULATION;

ANTINEOPLASTIC AGENTS; CELL DIFFERENTIATION; CYTOKINES; DENDRITIC CELLS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; IMMUNOLOGIC FACTORS; INTERLEUKIN-4; MONOCYTES; POLYSACCHARIDES; T-LYMPHOCYTES; TH1 CELLS;

EID: 55249086579     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2008.08.007     Document Type: Article

References (33)

1. Duarte M.E., Cardoso M.A., Noseda M.D., and Cerezo A.S. Structural studies on fucoidans from the brown seaweed Sargassum stenophyllum. Carbohydr Res 333 4 (2001) 281-293
2. Bilan M.I., Grachev A.A., Shashkov A.S., Nifantiev N.E., and Usov A.I. Structure of a fucoidan from the brown seaweed Fucus serratus L. Carbohydr Res 341 2 (2006) 238-245
3. Chandía N.P., and Matsuhiro B. Characterization of a fucoidan from Lessonia vadosa (Phaeophyta) and its anticoagulant and elicitor properties. Int J Biol Macromol 42 3 (2008) 235-240
4. Cumashi A., Ushakova N.A., Preobrazhenskaya M.E., D'Incecco A., Piccoli A., and Totani L. A comparative study of the anti-inflammatory, anticoagulant, antiangiogenic, and antiadhesive activities of nine different fucoidans from brown seaweeds. Glycobiology 17 5 (2007) 541-552
5. Hayashi K., Nakano T., Hashimoto M., Kanekiyo K., and Hayashi T. Defensive effects of a fucoidan from brown alga Undaria pinnatifida against herpes simplex virus infection. Int Immunopharmacol 8 1 (2008) 109-116
6. Alekseyenko T.V., Zhanayeva S.Y., Venediktova A.A., Zvyagintseva T.N., Kuznetsova T.A., Besednova N.N., et al. Antitumor and antimetastatic activity of fucoidan, a sulfated polysaccharide isolated from the Okhotsk Sea Fucus evanescens brown alga. Bull Exp Biol Med 143 6 (2007) 730-732
7. Nakamura T., Suzuki H., Wada Y., Kodama T., and Doi T. Fucoidan induces nitric oxide production via p38 mitogen-activated protein kinase and NF-kappaB-dependent signaling pathways through macrophage scavenger receptors. Biochem Biophys Res Commun 343 1 (2006) 286-294
8. Choi E.M., Kim A.J., Kim Y.O., and Hwang J.K. Immunomodulating activity of arabinogalactan and fucoidan in vitro. J Med Food 8 4 (2005) 446-453
9. Maruyama H., Tamauchi H., Hashimoto M., and Nakano T. Antitumor activity and immune response of Mekabu fucoidan extracted from Sporophyll of Undaria pinnatifida. In Vivo 17 3 (2003) 245-249
10. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y.J., et al. Immunobiology of dendritic cells. Annu Rev Immunol 18 (2000) 767-811
11. Kapsenberg M.L. Dendritic-cell control of pathogen-driven T-cell polarization. Nat Rev Immunol (2003) 984-993
12. Moser M., and Murphy K.M. Dendritic cell regulation of TH1-TH2 development. Nat Immunol 1 (2000) 199-205
13. Moser M. Regulation of Th1/Th2 development by antigen-presenting cells in vivo. Immunobiology 204 (2001) 551-557
14. Sallusto F., Cella M., Danieli C., and Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med 182 (1995) 389-400
15. Reis e Sousa C., Stahl P.D., and Austyn J.M. Phagocytosis of antigens by Langerhans cells in vitro. J Exp Med 178 (1993) 509-519
16. O'Garra A. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity 8 3 (1998) 275-283
17. Takayama T., Tahara H., and Thomson A.W. Transduction of dendritic cell progenitors with a retroviral vector encoding viral interleukin-10 and enhanced green fluorescent protein allows purification of potentially tolerogenic antigen-presenting cells. Transplantation 68 (1999) 1903-1909
18. Ribas A. Clinical trials with tumor antigen genetically modified dendritic cells. Semin Oncol 32 6 (2005) 556-562
19. Märten A., Renoth S., Heinicke T., Albers P., Pauli A., and Mey U. Allogeneic dendritic cells fused with tumor cells: preclinical results and outcome of a clinical phase I/II trial in patients with metastatic renal cell carcinoma. Hum Gene Ther 14 5 (2003) 483-494
20. Su Z., Dannull J., Heiser A., Yancey D., Pruitt S., and Madden J. Immunological and clinical responses in metastatic renal cancer patients vaccinated with tumor RNA-transfected dendritic cells. Cancer Res 63 9 (2003) 2127-2133
21. Fuessel S., Meye A., Schmitz M., Zastrow S., Linné C., and Richter K. Vaccination of hormone-refractory prostate cancer patients with peptide cocktail-loaded dendritic cells: results of a phase I clinical trial. Prostate 66 8 (2006) 811-821
22. Tan P.H., Beutelspacher S.C., Wang Y.H., McClure M.O., Ritter M.A., and Lombardi G. Immunolipoplexes: an efficient, nonviral alternative for transfection of human dendritic cells with potential for clinical vaccination. Mol Ther 11 5 (2005) 790-800
23. Sheng K.C., Pietersz G.A., Wright M.D., and Apostolopoulos V. Dendritic cells: activation and maturation-applications for cancer immunotherapy. Curr Med Chem 12 15 (2005) 1783-1800
24. Renkl A.C., Wussler J., Ahrens T., Thoma K., Kon S., and Uede T. Osteopontin functionally activates dendritic cells and induces their differentiation toward a Th1-polarizing phenotype. Blood 106 (2005) 946-955
25. Bain C., Fatmi A., Zoulim F., Zarski J.P., Trepo C., and Inchauspe G. Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection. Gastroenterology 120 (2001) 512-524
26. Tan M.C., Mommaas A.M., Drijfhout J.W., Jordens R., Onderwater J.J., and Verwoerd D. Mannose receptor-mediated uptake of antigens strongly enhances HLA class II-restricted antigen presentation by cultured dendritic cells. Eur J Immunol 27 9 (1997) 2426-2435
27. Amigorena S. Fc gamma receptors and cross-presentation in dendritic cells. J Exp Med 195 1 (2002) F1-F3
28. Cambi A., Gijzen K., de Vries J.M., Torensma R., Joosten B., Adema G.J., et al. The C-type lectin DC-SIGN (CD209) is an antigen-uptake receptor for Candida albicans on dendritic cells. Eur J Immunol 33 2 (2003) 532-538
29. Trinchieri G. The two faces of interleukin 12: a pro-inflammatory cytokine and a key immunoregulatory molecule produced by antigen-presenting cells. discussion in Ciba Found Symp. 195: 214-20. Ciba Found Symp 195 (1995) 203-214
30. Kadowaki N., Antonenko S., Lau J.Y., and Liu Y.J. Natural interferon alpha/beta-producing cells link innate and adaptive immunity. J. Exp Med 192 2 (2000) 219-226
31. Culley F.J., Pennycook A.M., Tregoning J.S., Hussell T., and Openshaw P.J. Differential chemokine expression following respiratory virus infection reflects Th1- or Th2-biased immunopathology. J Virol 80 9 (2006) 4521-4527
32. Ohshima Y., Yang L.P., Uchiyama T., Tanaka Y., Baum P., and Sergerie M. OX40 costimulation enhances interleukin-4 (IL-4) expression at priming and promotes the differentiation of naive human CD4(+) T cells into high IL-4-producing effectors. Blood 92 9 (1998) 3338-3345
33. Shurin M.R., Lu L., Kalinski P., Stewart-Akers A.M., and Lotze M.T. Th1/Th2 balance in cancer, transplantation and pregnancy. Springer Semin Immunopathol 21 3 (1999) 339-359